Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02480452
Other study ID # S57844
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2015
Est. completion date June 2019

Study information

Verified date June 2015
Source Universitaire Ziekenhuizen KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The overall goal of this research proposal is the early prediction of the emergence of CVI and its characteristics on the basis of neuroimaging data. The different steps that will be taken to achieve this goal will be: 1. To characterize CVI deficits in children; 2. To correlate the CVI characteristics with their motor profiles; 3. To characterize brain lesions in children with CVI; 4. To link the motor profile, CVI profile and brain metrics of the children. Over the last 10 years, 488 children with and without CP have consulted at the CVI clinic in Leuven. All these children had a comprehensive visual perceptual assessment, cognitive evaluation and an ophthalmological assessment. Summarizing these data results in a quantitative visual perceptual profile for each individual patient. The goal is to prospectively extend this database to a number of 600 children. The project's primary objective is to relate the presence of CVI to the motor profiles of these children. Of these 488 children, 300 have an MRI available. The goal is to analyze the retrospective MRI data of this clinical group and to prospectively extend this database by reassuring newly registered children will receive MRI with DTI. This will allow the investigation of the correlation between the brain metrics and the CVI characteristics in a large cohort.


Description:

Objective 1 &2: to investigate the relationship between the presence of CVI and the motor profiles of children diagnosed with CVI. Part 1 Retrospective data A database, registering all children diagnosed with or at risk for CVI, is available through the Centre For Developmental Disabilities, Leuven. All these children have consulted at the CVI clinic. Their developmental age ranges between 3 and 6 years. All these children have had a thorough work-up, so that information is available regarding the diagnosis of CVI (L94 visual perceptual battery test score10 and CVI questionnaire11), the cognitive abilities of the child (performance and verbal IQ using WISC-II, SON-R or WPPSI-III-NL) together with the test results regarding motor functioning: visuospatial functioning (VMI12 and TVPS13), motor coherence tasks and gross motor function (movement ABC14). All children standardly received a complete ophthalmological assessment. The consensus eye protocol, as introduced by the Flemish working group on CVI, was performed in each child, evaluating fixation of eyes, position and motility, acuity, refraction, contrast sensitivity, visual field, visual attention and viewing distance. Part 2 Prospective data The database will continuously be updated and therefore, data from all new consulting children will be added consecutively. Prospectively, a new test for the diagnosis of CVI will be applied. It concerns a newly developed tool for diagnosis of CVI, based on the L-POST and developed in collaboration with the research group of J. Wagemans. Normative data have been gathered for the age ranges 3 to 6 years. The diagnosis of CVI is made by comparing the results of the visual perceptual tests to the developmental age of the child, with a result


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date June 2019
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 3 Years to 6 Years
Eligibility Inclusion Criteria: - mental age between 3 y and 6 y - suspicion of CVI Exclusion Criteria: - mental age below 3y

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium Centre for Developmental disabilities Leuven Flanders

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary L94 visual perceptual battery Diagnostic assessment for CVI baseline
Primary FIORI scale Outcome parameters for quantitative scoring of brain MRI baseline
Secondary Visual motor assessment Visual Motor Integration Test (VMI); Test of Visual Percepual Skills (TVPS) baseline
Secondary Gross motor function Movement ABC baseline
Secondary Motion coherence tasks Standardized test evaluating motion coherence baseline